Daniel R. Schimmel, MD, explains how balloon pulmonary angioplasty (BPA) uses balloons and specialized catheters to open narrowed vessels in the lungs to improve circulation and reduce symptoms…
Nick Norwitz interviews Aseem Malhotra, MD, a consultant cardiologist, on controversial new findings challenging LDL cholesterol’s role as an independent risk factor for heart disease. They discuss data…
NEW YORK (Reuters Health) – Drug eluting stents (DES) apparently deliver drug to downstream coronary vessels and reduce the rate new lesion formation therein, a Cleveland Clinic team…
NEW YORK (Reuters Health) – Among stable patients with persistent total occlusion of the infarct-related artery after myocardial infarction, those who undergo late percutaneous coronary intervention (PCI) fare…
NEW YORK (Reuters Health) – Statin therapy before and during acute ischemic stroke hospitalization is associated with improved poststroke survival, and going off statin therapy in the hospital…
NEW YORK (Reuters Health) – Contrary to some previous results, intracoronary administration of a bolus of adenosine before elective percutaneous coronary intervention does not reduce periprocedural myocardial necrosis,…
NEW YORK (Reuters Health) – In patients with concomitant cardiac disease requiring surgery and symptomatic carotid artery disease, carotid artery stenting before surgery yields favorable outcomes, a Dutch…
NEW YORK (Reuters Health) – Insulin resistance shows no significant association with an increased risk of atrial fibrillation, researchers report in an October 14th on-line paper in the…
NEW YORK (Reuters Health) – Diuretic use is associated with an increased incidence of gout, an association mediated by increases in serum urate levels, according to findings published…
NEW YORK (Reuters Health) – For stable patients with left main coronary artery disease, percutaneous coronary intervention (PCI) is a “reasonable” alternative to coronary artery bypass grafting (CABG)…
NEW YORK (Reuters Health) – In patients with chronic coronary artery disease, prasugrel overcomes high on-clopidogrel platelet reactivity more effectively than doubling the dose of clopidogrel, results of…
NEW YORK (Reuters Health) – More intensive blood glucose lowering won’t reduce the risk of heart failure in patients with type 2 diabetes, and when achieved with a…
